---
title: Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery
  for Brain Metastases From <em>EGFR</em> and <em>ALK</em> Oncogene-Driven Non-Small
  Cell Lung Cancer (TURBO-NSCLC)
date: '2024-07-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39047224/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240726182848&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'CONCLUSION: The addition of up-front SRS to CNS-penetrant TKI improved
  time-to-CNS progression and local CNS control, but not OS, in patients with BM from
  EGFR- and ALK-driven NSCLC. Patients with larger BM (≥1 cm) may benefit the most
  from up-front ...'
disable_comments: true
---
CONCLUSION: The addition of up-front SRS to CNS-penetrant TKI improved time-to-CNS progression and local CNS control, but not OS, in patients with BM from EGFR- and ALK-driven NSCLC. Patients with larger BM (≥1 cm) may benefit the most from up-front ...